Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Electrocore LLC

Healthcare US ECOR

8.72USD
-1.22(12.27%)

Last update at 2026-06-05T20:00:00Z

Day Range

8.559.97
LowHigh

52 Week Range

4.168.64
LowHigh

Fundamentals

  • Previous Close 9.94
  • Market Cap50.12M
  • Volume132306
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.65200M
  • Revenue TTM32.03M
  • Revenue Per Share TTM3.78
  • Gross Profit TTM 27.79M
  • Diluted EPS TTM-1.65

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -13.96300M -11.97900M -19.02000M -22.59300M -18.06930M
Minority interest - - - - -
Net income -13.96600M -11.88600M -18.83400M -22.16200M -17.21810M
Selling general administrative 38.21M 31.20M 26.44M 24.33M 21.57M
Selling and marketing expenses - - - - -
Gross profit 27.79M 21.40M 13.23M 6.98M 4.07M
Reconciled depreciation 1.68M 1.26M 0.88M 0.55M 0.38M
Ebit -13.15300M -12.16200M -19.02000M -23.42200M -20.04310M
Ebitda -11.47800M -10.90400M -17.76000M -22.87400M -22.01450M
Depreciation and amortization 1.68M 1.26M 1.26M 0.55M -1.97140M
Non operating income net other - - - - -
Operating income -13.15300M -12.16200M -18.80500M -22.87400M -20.04310M
Other operating expenses 45.19M 37.34M 34.84M 31.47M 25.49M
Interest expense 0.59M 0.39M - 0.29M 4.33M
Tax provision 0.00300M -0.09300M -0.19700M -0.43100M -0.85117M
Interest income 0.30M 0.57M 0.44M 0.29M 0.01M
Net interest income -0.29200M 0.57M 0.44M 0.29M 0.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00300M -0.09300M -0.18600M -0.43100M -0.85120M
Total revenue 32.03M 25.18M 16.03M 8.59M 5.45M
Total operating expenses 40.94M 33.56M 32.03M 29.85M 24.11M
Cost of revenue 4.24M 3.79M 2.80M 1.62M 1.39M
Total other income expense net -0.81000M 0.18M -0.21500M 0.28M 1.97M
Discontinued operations - - - - -
Net income from continuing ops -13.96600M -11.88600M -20.59200M -22.16200M -17.21807M
Net income applicable to common shares - - - -22.16200M -17.21807M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 18.67M 20.47M 16.39M 24.76M 42.83M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets -2.65800M 1.29M 0.84M 0.83M 1.05M
Total liab 20.38M 12.93M 8.95M 7.67M 6.18M
Total stockholder equity -1.70900M 7.54M 7.44M 17.09M 36.65M
Deferred long term liab - - - - -
Other current liab 8.26M 6.50M 5.63M 4.69M 3.88M
Common stock 0.00800M 0.00700M 0.00600M 0.00500M 0.07M
Capital stock 0.00800M 0.00700M 0.00600M 0.00500M 0.07M
Retained earnings -191.05600M -177.09000M -165.20400M -146.37000M -124.20822M
Other liab - - - - -
Good will - - - - -
Other assets - - - 3.46M -0.00001M
Cash 7.04M 3.45M 10.58M 17.71M 34.69M
Cash and equivalents - - - - -
Total current liabilities 11.35M 9.15M 8.12M 7.04M 5.49M
Current deferred revenue - 0.08M 0.24M 0.15M -
Net debt 2.37M 0.69M -9.95500M -17.01300M -33.92803M
Short term debt 0.38M 0.36M 0.09M 0.07M 0.06M
Short long term debt - - - - -
Short long term debt total 9.40M 4.14M 0.63M 0.70M 0.76M
Other stockholder equity 189.24M 184.51M 172.70M 163.52M 160.77M
Property plant equipment - - - 0.61M 0.76M
Total current assets 11.61M 16.30M 14.29M 21.17M 37.54M
Long term investments - - - - -
Net tangible assets - - - 16.31M 36.13M
Short term investments 4.58M 8.52M - - 0.00000M
Net receivables 1.03M 1.37M 0.72M 0.40M 0.44M
Long term debt 6.61M - - - -
Inventory 1.63M 1.68M 2.16M 1.98M 1.36M
Accounts payable 2.71M 1.83M 2.16M 2.13M 1.54M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.10M 0.11M -0.06400M -0.06900M 0.01M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 7.06M 0.27M 1.10M 2.97M 4.53M
Deferred long term asset charges - - - - -
Non current assets total 7.06M 4.17M 2.09M 3.58M 5.29M
Capital lease obligations 2.80M 4.14M 0.63M 0.70M 0.76M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 3.94M -8.51900M -0.16500M 0.00000M 18.22M
Change to liabilities - - - 1.19M 0.46M
Total cashflows from investing activities 3.88M -8.51900M -0.20600M - 18.22M
Net borrowings 7.50M 0.00000M - - -
Total cash from financing activities 7.63M 8.44M 7.49M 0.00000M 25.68M
Change to operating activities - - - 0.52M 1.01M
Net income -13.96600M -11.88600M -18.83400M -22.16200M -17.21807M
Change in cash 3.33M -6.88100M -7.38100M -16.72700M 30.45M
Begin period cash flow 3.70M 10.58M 17.96M 34.69M 4.24M
End period cash flow 7.04M 3.70M 10.58M 17.96M 34.69M
Total cash from operating activities -8.18700M -6.94800M -14.66800M -16.64500M -13.62762M
Issuance of capital stock 0.22M 8.30M 8.14M 0.00000M 25.68M
Depreciation 1.68M 1.26M 1.02M 0.55M 0.38M
Other cashflows from investing activities - -8.51900M - - -
Dividends paid - - 0.00000M - -
Change to inventory 0.02M 0.71M 0.10M 0.30M 0.37M
Change to account receivables -0.14200M -0.71000M -0.26200M 0.04M -0.21719M
Sale purchase of stock - - - - -
Other cashflows from financing activities 7.63M 0.14M -0.65700M - 18.22M
Change to netincome - - - 2.93M 1.58M
Capital expenditures 0.07M 0.00000M 0.21M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.32M 1.76M 0.81M 2.04M 1.63M
Stock based compensation 1.93M 1.87M 1.70M 2.68M 3.30M
Other non cash items 0.85M 0.05M 0.63M 0.24M -0.01178M
Free cash flow -8.25300M -6.94800M -14.87400M -16.64500M -13.62762M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ECOR
Electrocore LLC		 -1.22 12.27% 8.72 - 384.62 1.56 41.88 1.52 0.16
ABT
Abbott Laboratories		 0.29 0.32% 91.07 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 4.45 1.48% 305.66 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.26 0.32% 81.67 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.3 0.61% 48.55 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Electrocore LLC

200 Forge Way, Rockaway, NJ, United States, 07866

Key Executives

Name Title Year Born
Mr. Daniel S. Goldberger CEO & Director 1959
Mr. Joseph P. Errico Co-Founder, Principal Investor & Director 1969
Dr. Thomas J. Errico M.D. Founder, Independent Director & Principal Investor 1952
Mr. Brian M. Posner CFO & Corp. Sec. 1962
Mr. Michael Romaniw Exec. VP of Systems & Operations 1957
Ms. Jackie Dorsky VP of Marketing NA
Mr. Iain Strickland Ph.D. Sr. VP of Global Sales & Strategy NA
Ms. Carrie Kochek Sr. Director of HR NA
Dr. Peter S. Staats M.B.A., M.D. Chief Medical Officer 1963
Mr. Eric J. Liebler Sr. VP of Neurology 1964

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.